Clinical outcomes following switch from venlafaxine ER to desvenlafaxine in nonresponders and responders

Author： Guico-Pabia C.J.   Jiang Q.   Ninan P.T.   Thase M.E.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.27, Iss.9, 2011-09, pp. : 1815-1826

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders

By  

Transfusion Medicine and Hemotherapy, Vol. 41, Iss. 6, 2014-11 ,pp. : 420-429

Karger

Access to resources Recommend Favorite

An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 690-700

John Wiley & Sons Inc

Access to resources Recommend Favorite

An abnormality in glucocorticoid receptor expression differentiates steroid responders from nonresponders in keloid disease

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 690-700

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comparison of Outcomes Following a Switch From a Brand to an Authorized Versus Independent Generic Drug

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 103, Iss. 2, 2018-02 ,pp. : 310-317

John Wiley & Sons Inc

Access to resources Recommend Favorite

IMMUNOGLOBULIN TREATMENT IN POST-POLIO SYNDROME: IDENTIFICATION OF RESPONDERS AND NON-RESPONDERS

By Östlund Gunilla   Broman Lisbet   Werhagen Lars   Borg Kristian  

Journal of Rehabilitation Medicine, Vol. 47, Iss. 8, 2015-09 ,pp. : 727-733

Medical Journals Limited

Access to resources Recommend Favorite